VKH
MRNS

Virtu KCG Holdings’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Virtu KCG Holdings’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,135
Closed -$114K – 3612
2017
Q1 		$114K Buy
16,135
+3,673
+29% +$19.7K ﹤0.01% 2644
2016
Q4 		$50K Sell
12,462
-10,054
-45% -$46.8K ﹤0.01% 3086
2016
Q3 		$164K Buy
+22,516
New +$152K ﹤0.01% 2466

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's MRNS Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2017, closing a stake of 16,135 shares — an estimated $114K sold.

Virtu KCG Holdings first reported a position in MRNS in Q3 2016 and held it in 3 quarters. The position peaked at $164K in Q3 2016. 24 funds tracked by Wall St. Rank hold MRNS as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 16,135 Marinus Pharmaceuticals, Inc shares in Q2 2017, an estimated $114K.
  • Virtu KCG Holdings first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 3 quarters.
  • Virtu KCG Holdings's Marinus Pharmaceuticals, Inc position peaked at $164K in Q3 2016.
  • 24 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.